[Form 4] Bunge Global SA Insider Trading Activity

Rhea-AI Filing Summary

Bunge Global SA (BG) reported an insider transaction by its Executive VP, Global Markets. On 11/21/2025, the officer exercised stock options to acquire 5,300 shares of common stock at an exercise price of $50.07 per share and then sold shares on the same day.

The reported sales included 5,300 shares of common stock at a weighted average price of $94.3823 per share (from trades between $94.30 and $94.48) and an additional 20,000 shares at a weighted average price of $94.3709 per share (from trades between $94.28 and $94.44). After these transactions, the officer beneficially owned 104,536.808 shares of Bunge Global SA common stock directly.

The derivative position reported was a stock option (right to buy) for 5,300 shares at $50.07, which was exercised on 11/21/2025, leaving 0 such derivative securities owned. The option had become exercisable in three equal annual installments beginning on March 1, 2017.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dimopoulos Christos

(Last) (First) (Middle)

C/O BUNGE GLOBAL SA

1391 TIMBERLAKE MANOR PARKWAY

(Street)

CHESTERFIELD MO 63017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bunge Global SA [ BG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive VP, Global Markets

3. Date of Earliest Transaction (Month/Day/Year)
11/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/21/2025		M		5,300	A	$50.07	129,836.808	D
Common Stock	11/21/2025		S		5,300	D	$94.3823(1)	124,536.808	D
Common Stock	11/21/2025		S		20,000	D	$94.3709(2)	104,536.808	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to buy)	$50.07	11/21/2025		M			5,300	(3)	03/01/2026	Common Stock	5,300	$0	0	D

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $94.30 to $94.48. The price reported reflects the weighted average sale price. The reporting person undertakes to provide to Bunge Global SA, any security holder of Bunge Global SA, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.

2. This transaction was executed in multiple trades at prices ranging from $94.28 to $94.44. The price reported reflects the weighted average sale price. The reporting person undertakes to provide to Bunge Global SA, any security holder of Bunge Global SA, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.

3. This option became exercisable in three equal annual installments beginning on March 1, 2017.

Remarks:

	/s/ Drew Yaeger, Attorney-in-Fact	11/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Bunge Global SA (BG) report on this Form 4?

The filing reports that the Executive VP, Global Markets of Bunge Global SA (BG) exercised stock options for 5,300 shares of common stock at $50.07 per share and sold shares of common stock on 11/21/2025.

How many Bunge Global SA shares did the insider sell on 11/21/2025?

The insider sold 5,300 shares of common stock at a weighted average price of $94.3823 per share and an additional 20,000 shares at a weighted average price of $94.3709 per share on 11/21/2025.

What is the insider’s remaining ownership in Bunge Global SA (BG) after the reported transactions?

Following the reported transactions, the Executive VP, Global Markets beneficially owned 104,536.808 shares of Bunge Global SA common stock, held directly.

What stock option was exercised in this Bunge Global SA Form 4 filing?

The filing shows a stock option (right to buy) for 5,300 shares of common stock with an exercise price of $50.07 per share, which was exercised on 11/21/2025. After exercise, 0 such derivative securities remained owned.

How were the sale prices for the Bunge Global SA shares determined in the Form 4?

The sales at $94.3823 and $94.3709 per share are reported as weighted average prices. The transactions were executed in multiple trades within price ranges of $94.30–$94.48 and $94.28–$94.44, respectively.

When did the reported Bunge Global SA stock option become exercisable?

The option for 5,300 shares became exercisable in three equal annual installments beginning on March 1, 2017, according to the explanation of responses.